Treatment options for

metastatic urothelial carcinoma:

eLearning activities

Publication date: 11 May 2022

Accreditation expiration date: 11 May 2023

Estimated time to complete: 15 minutes

Activity 3: Use of predictive factors for optimal selection of maintenance therapy in patients with mUC

In this eLearning video module, Axel Merseburger will discuss the need to develop a process to guide patient selection in order to achieve superior outcomes and evaluate clinical data behind potential predictive factors that could change the management of metastatic UC.

Learning objectives

After completing this activity, you will be able to:

Discuss the importance of predictive factors for determining which patients may benefit from therapy
Identify predictive factors that could guide treatment decision for maintenance therapy
Interpret clinical data behind these factors understanding how these could change the management of mUC

Login to access this activity

No account? Create a free account now

Email*
Password*
Enter Password Confirm Password
Healthcare Professional*
(Required) I confirm that I am a healthcare professional*
Privacy Acceptance*
(Required) I have read and accept the terms of the Privacy notice and the Terms and Conditions and consent to receive e-alerts from Springer Healthcare IME pertinent to my area of interest. I can withdraw my consent at any time by contacting IME@springer.com or via the ‘unsubscribe’ link included in any email communications*
SHE Communication Preferences
(Optional) I agree that my email address will be used by our sister site Medicine Matters Oncology, as per their Privacy Policy, for the purposes of communicating to me details of educational content pertinent to Oncology. I can withdraw my consent at any time by contacting medicinematters@springer.com or via the ‘unsubscribe’ link included in any email communications.
Phone
This field is for validation purposes and should be left unchanged.

Module Content

Sections Status